Multiple myeloma long-term survivors display sustained immune alterations decades after first line therapy https://www.biorxiv.org/content/10.1101/2023.05.27.542555v1?med=mas
QOTO: Question Others to Teach Ourselves An inclusive, Academic Freedom, instance All cultures welcome. Hate speech and harassment strictly forbidden.